Literature DB >> 22100273

Distribution of dopamine D(2)-like receptors in the rat amygdala and their role in the modulation of unconditioned fear and anxiety.

M Perez de la Mora1, A Gallegos-Cari, M Crespo-Ramirez, D Marcellino, A C Hansson, K Fuxe.   

Abstract

Amygdaloid dopamine D(2) receptors play an important role in the modulation of fear/anxiety. Their topographical distribution within the amygdala is however unclear, and their role in unconditioned fear/anxiety remains largely unknown. The aim of this paper was to study the intra-amygdaloid distribution of D(2) receptors and to ascertain their role in unconditioned anxiety. Chemical anatomical studies in the rat, using D(2) and D(3)in situ hybridization, quantitative receptor autoradiography with either [(3)H]raclopride or [(125)I]sulpiride, and D(2)-like immunocytochemistry showed that the highest density of dopamine D(2) receptors is present in the central amygdaloid nucleus, particularly within its latero-capsular division, in which a D(2) but not a D(3) mRNA signal was observed. However, although at considerably reduced densities dopamine D(2) receptors were also found in other locations within the amygdala, including the basolateral nucleus. Behaviorally, the infusion of raclopride (0.75-4 μg/side) in the area of the central amygdaloid nucleus resulted at low doses in the appearance of anxiogenic-like effects in the Shock-Probe Burying test, whereas no effects of raclopride treatment were found at any dose in the Elevated Plus-Maze and the Open-Field test. Our results indicate that amygdaloid dopamine D(2)-like receptors have a topographically differentiated distribution within the rat amygdala, the major location being in the central amygdaloid nucleus. D(2)-like receptors play a role in the modulation of anxiety responses involving a potential differential function of D(2)-like receptors in the central amygdaloid nucleus versus the basolateral amygdaloid nucleus.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100273     DOI: 10.1016/j.neuroscience.2011.10.045

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala.

Authors:  D De Bundel; C Zussy; J Espallergues; C R Gerfen; J-A Girault; E Valjent
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

2.  Further studies on the hypothesis of PARP-1 inhibition as a strategy for lessening the long-term effects produced by perinatal asphyxia: effects of nicotinamide and theophylline on PARP-1 activity in brain and peripheral tissue : nicotinamide and theophylline on PARP-1 activity.

Authors:  C Allende-Castro; P Espina-Marchant; D Bustamante; E Rojas-Mancilla; T Neira; M A Gutierrez-Hernandez; D Esmar; J L Valdes; P Morales; P J Gebicke-Haerter; M Herrera-Marschitz
Journal:  Neurotox Res       Date:  2012-02-04       Impact factor: 3.911

3.  Targeted overexpression of CRH receptor subtype 1 in central amygdala neurons: effect on alcohol-seeking behavior.

Authors:  L Broccoli; S Uhrig; G von Jonquieres; K Schönig; D Bartsch; N J Justice; R Spanagel; W H Sommer; M Klugmann; A C Hansson
Journal:  Psychopharmacology (Berl)       Date:  2018-04-26       Impact factor: 4.530

4.  Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats.

Authors:  Jordan T Yorgason; Rodrigo A España; Joanne K Konstantopoulos; Jeffrey L Weiner; Sara R Jones
Journal:  Eur J Neurosci       Date:  2013-01-08       Impact factor: 3.386

5.  Organic cation transporter 3 and the dopamine transporter differentially regulate catecholamine uptake in the basolateral amygdala and nucleus accumbens.

Authors:  Katherine M Holleran; Jamie H Rose; Steven C Fordahl; Kelsey C Benton; Kayla E Rohr; Paul J Gasser; Sara R Jones
Journal:  Eur J Neurosci       Date:  2020-08-19       Impact factor: 3.386

6.  Reciprocal activation/inactivation of ERK in the amygdala and frontal cortex is correlated with the degree of novelty of an open-field environment.

Authors:  Frederico Velasco Sanguedo; Caio Vitor Bueno Dias; Flavia Regina Cruz Dias; Richard Ian Samuels; Robert J Carey; Marinete Pinheiro Carrera
Journal:  Psychopharmacology (Berl)       Date:  2015-12-19       Impact factor: 4.530

Review 7.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 8.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

9.  Korean Red Ginseng attenuates anxiety-like behavior during ethanol withdrawal in rats.

Authors:  ZhengLin Zhao; Young Woo Kim; YiYan Wu; Jie Zhang; Ju-Hee Lee; XiaoHua Li; Il Je Cho; Sang Mi Park; Dae Hwa Jung; Chae Ha Yang; Sang Chan Kim; RongJie Zhao
Journal:  J Ginseng Res       Date:  2014-06-07       Impact factor: 6.060

10.  Surface morphology of amygdala is associated with trait anxiety.

Authors:  Shuyu Li; Yanan Wang; Pengfei Xu; Fang Pu; Deyu Li; Yubo Fan; Gaolang Gong; Yuejia Luo
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.